Gate Square “Creator Certification Incentive Program” — Recruiting Outstanding Creators!
Join now, share quality content, and compete for over $10,000 in monthly rewards.
How to Apply:
1️⃣ Open the App → Tap [Square] at the bottom → Click your [avatar] in the top right.
2️⃣ Tap [Get Certified], submit your application, and wait for approval.
Apply Now: https://www.gate.com/questionnaire/7159
Token rewards, exclusive Gate merch, and traffic exposure await you!
Details: https://www.gate.com/announcements/article/47889
Why Long-Term Investors Keep Coming Back to Coca-Cola for Dividend Growth
A Valuation Window That Rarely Opens
The beverage sector occasionally presents pricing anomalies that create opportunities for disciplined investors. Right now, Coca-Cola (NYSE: KO) is trading at price-to-earnings and price-to-book ratios both sitting below their five-year historical averages. While the yield and price-to-sales metrics hover around their typical ranges, the overall package suggests the market may be undervaluing this cash-generation machine relative to its recent history.
This pricing inefficiency stems largely from sector-wide caution surrounding consumer staples, where shifting consumer preferences have created uncertainty. For those seeking best longterm stocks to hold, such disconnects between valuation and fundamentals deserve serious attention.
The Dividend Track Record That Stands Out
When evaluating dividend sustainability, consistency matters more than raw percentage points. Coca-Cola’s board has demonstrated unwavering commitment to shareholder returns through 63 consecutive years of annual dividend increases—positioning the company as a bonafide Dividend King and placing it among the elite five longest-running streaks globally.
This isn’t theoretical commitment. The track record spans multiple economic cycles, market crashes, and industry disruptions. For investors prioritizing reliable income streams through various market environments, this longevity speaks louder than any quarterly earnings beat.
The 2.9% yield might not dominate the consumer staples landscape—some peers offer north of 3.9%—but it significantly outpaces the broader S&P 500’s meager 1.1% yield. When weighted against sector peers averaging 2.7%, Coca-Cola’s combination of income generation and business momentum creates a compelling risk-reward profile.
Operational Momentum Where It Matters
The real differentiation emerges in execution. Coca-Cola’s third-quarter 2025 organic sales expanded 6%, mirrored by a 6% jump in adjusted earnings. This performance occurs precisely when the broader consumer staples sector grapples with headwinds from changing consumption patterns.
The contrast with category competitors proves illuminating. A key peer experienced organic sales growth of just 1.3% with adjusted earnings declining 2% during the same period. This gap between Coca-Cola’s outperformance and competitor underperformance reflects superior business positioning rather than cyclical advantages.
The company’s scale enables it to function as an industry consolidator, deploying acquisitions strategically to expand brand reach and product assortment. Combined with best-in-class distribution networks and marketing capabilities, Coca-Cola operates with structural advantages in a sector renowned for weathering economic volatility.
What Matters for Buy-and-Hold Strategies
Investors pursuing best longterm stocks face a critical question: Can this company weather multiple business cycles while maintaining dividend growth?
Coca-Cola addresses this through three reinforcing elements. First, beverages function as recession-resistant categories—consumption patterns prove surprisingly stable through economic downturns. Second, the company’s current operational momentum demonstrates it’s stealing market share rather than merely defending turf. Third, the valuation window suggests you’re not overpaying for this quality.
The real test for any hold-forever strategy involves selecting management teams that prioritize consistent shareholder returns. Coca-Cola’s 63-year dividend increase streak suggests the board takes that mandate seriously. When combined with reasonable pricing and solid business fundamentals, the ingredients align for patient capital.
This appears less like a high-risk speculation and more like a sensible allocation for those building income-generating portfolios designed for the long haul.